Latest database descriptions

The aims of this study are:
— to identify determinants that influence resistance or sensitivity following adjuvant treatment with Herceptin®;
— to identify determinants of cardiac toxicity following adjuvant treatment with Herceptin®;
— to identify genetic determinants for developing different types of breast cancer: HER2+, triple negative, RH+;
— to identify genetic determinants for developing breast cancer.

Main objective
To assess the impact of maternal vulnerability factors on childbirth, child and maternal outcome, as well as break down the mechanisms linking vulnerable conditions to increased perinatal and maternal risk.
Secondary aims:
— to study the impact of serious events on vulnerable women by exclusive monitoring in one hospital in relation to monitoring within the city hospital network;
— to study the treatment path for vulnerable women;
— to answer questions posed by additional studies;
— to identify risk factors of increased post-partum haemorrhaging;
— assess the impact of maternal vulnerability on immunobiological development in HIV-infected pregnant women (in partnership with the EPF-ANRS cohort)
— assess the impact of maternal vulnerability on systemic errors and avoiding such errors in relation to the onset of serious adverse events during pregnancy: (PREVIANS)
— Definition of normal values for various biological markers (PreCARE Bio)
— to identify social and economic factors that determine healthcare consumption in pregnant women (URC ECO APHP)
— to identify social and economic factors that determine healthcare consumption in newborns (0 to 28 days old) (URC ECO APHP)

Teen suicide attempts (SA) are a significant public health concern that have led to numerous scientific studies, but few involving young adolescents. We studied the epidemiological characteristics and psychological outcome for adolescents that were admitted to a paediatric emergency unit in Marseilles for attempted suicide over 1 year, given the existence of a city hospital network in charge of monitoring these patients.

This database aims to:
– Better document the patient and his/her disease
– Improve healthcare network organisation
– Make rare diseases visible and help regulatory reporting
– Better harness the potential of large national databases
– Improve research within the field